GlassScriptPhysician profile
Henry Fieldon Stroope
NPI 1417913567
$7,586.88
in general payments reported to CMS, 2019-2025
24 companies · $216 in 2025
The $216 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,564 · 2020: $35.98 · 2021: $125 · 2022: $185 · 2023: $3,324 · 2024: $138 · 2025: $216.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,514 · Food and Beverage: $1,164.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,513.68 |
| Food and Beverage | $1,163.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Encore Medical, LP | $2,017.02 | 2019 | |
| Stryker Corporation | $1,818.98 | 2019-2025 | Blueprint Patient Specific Instrumentation, 1788 |
| Shoulder Innovations, INC. | $1,407.39 | 2023 | Inset System |
| Zimmer Biomet Holdings, INC. | $787.41 | 2019 | |
| Omnilife Science, INC | $500.92 | 2019 | |
| Fx Shoulder Solutions, INC | $166.72 | 2019 | |
| Smith+Nephew, INC. | $158.94 | 2023-2025 | Bioinductive Implant With Arthroscopic Delivery System - Medium, Healicoil, Aetos Shoulder System |
| Pylant Medical | $154.67 | 2022-2023 | |
| Medline Industries LP | $125.03 | 2021 | |
| Midsouth Orthopedics INC. | $51.16 | 2023-2025 | |
| Horizon Therapeutics Plc | $51.15 | 2022 | |
| Pfizer INC. | $50.34 | 2019-2022 | |
| Pacira Therapeutics, INC. | $43.65 | 2019-2020 | |
| Djo, LLC | $38.64 | 2025 | Cmf |
| Heron Therapeutics, INC. | $35.18 | 2025 | Zynrelef |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solventum Corporation | $26.74 | 2024 | Prevena |
| Vertex Pharmaceuticals Incorporated | $26.66 | 2025 | |
| Skeletal Dynamics INC | $24.45 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $22.50 | 2025 | Exparel |
| Amgen INC. | $20.17 | 2025 | |
| Ferring Pharmaceuticals INC. | $16.21 | 2022 | |
| Bioventus LLC | $15.95 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $15.68 | 2022 | |
| Sanofi-Aventis U.S. LLC | $11.32 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Henry Stroope listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.